Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis

By sjmartinez • February 28, 2023

Kuraji R, Shiba T, Dong TS, Numabe Y, Kapila YL. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis. World J Gastroenterol. 2023 Feb 14;29(6):967-996. doi: 10.3748/wjg.v29.i6.967. PMID: 36844143; PMCID: PMC9950865.

Tags: Digestive Diseases, Dysbiosis, Metabolic syndrome, Microbiota, Nonalcoholic fatty liver disease, Periodontal disease, probiotics, Publications

The PTPN2 rs1893217 IBD risk allele increases susceptibility to AIEC invasion by a JAK-STAT-CEACAM6 axis

Chatterjee P, Canale V, King SJ, Shawki A, Lei H, Santos AN, Haddad M, Gries C, McGovern DPB, Borneman J, McCole DF. The PTPN2 rs1893217 IBD risk[...]

Distal esophageal acid exposure and poor esophageal clearance correlate with probability of progression in Barrett’s esophagus as determined by the tissue systems pathology test

Eriksson SE, Kolb JM, Nguyen J, Sarici IS, Zheng P, Ayazi S. Distal esophageal acid exposure and poor esophageal clearance correlate with probability of progression[...]

Impact of Short Duration FODMAP Restriction on Breath Gases and Gastrointestinal Symptoms

Pathipati MP, Shortt A, Shortt C, McBride B, O'Rourke L, Burke R, Chey WD, Chang L, Staller K. Impact of Short Duration FODMAP Restriction on[...]